Youngil Koh

21PUBLICATIONS
110CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical virologyPredictive and prognostic markersMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jun 24, 2026
Nuanced treatment decision in newly diagnosed multiple myeloma patients aged 65-75 years: a real-world study.

|Jun 12, 2026
Anbalcabtagene autoleucel (PD-1 and TIGIT knockdown CD19 CAR-T) for relapsed/refractory large B-cell lymphoma (CRC01-01).

|Jan 15, 2026
Infections after bispecific antibodies in B-cell lymphomas.

Dong Hyun Kim, Naryllae Lee, Youngil Koh

|Dec 04, 2025
Clinical Outcomes of Low-Grade Cytomegalovirus DNAemia in Hematopoietic Stem Cell Transplantation Recipients Receiving Letermovir Prophylaxis.

Jung Soo Son, Eun-Jeong Jeong, Hyeon Jae Jo

|Mar 11, 2025
Comprehensive clinico-genetic analysis reveals prognostic factors of blastic plasmacytoid dendritic cell neoplasm.

Ji Hyun Lee, Sung-Yong Oh, Taek Gyu Lee

|Jan 10, 2025
Increased local DNA methylation disorder in AMLs with DNMT3A-destabilizing variants and its clinical implication.

Dohoon Lee, Bonil Koo, Seokhyeon Kim

Pageof 4

Frequent Collaborators

11 joint publications

Jamin Byun

11 joint publications

Sung-Soo Yoon

6 joint publications

Junshik Hong

5 joint publications

Dong-Yeop Shin